UroSig-Reeval: statistical analysis plan (version 2), amendments and post hoc analyses for an external re-evaluation of published transcriptomic prognostic signatures for prostate cancer

Statistical analysis plan (SAP v2) of UroSig-Reeval, an external re-evaluation of published transcriptomic prognostic signatures for prostate cancer in independent public cohorts, with an English translation and a list of all amendments and post hoc analyses. The plan was finalised on 11 November 2026, before any outcome data were read. It was not registered prospectively and is made public here after the analyses were completed. The original Chinese PDF is the authoritative version (SHA-256 dc9965d5662bfbb408ffbd68f5ef90c57991e4a9765f0a326f7f54745694f110). Jin Zhao and Song Xue contributed equally. Correspondence: Xiang Wan.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24385587
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

UroSig-Reeval: statistical analysis plan (version 2), amendments and post hoc analyses for an external re-evaluation of published transcriptomic prognostic signatures for prostate cancer

Song Xue, Wei Lei, Xiang Wan, Tubin Yuan et al.
3 links
Zenodo (CERN European Organization for Nuclear Research)
Prostate Cancer Treatment and Research
article

UroSig-Reeval: statistical analysis plan (version 2), amendments and post hoc analyses for an external re-evaluation of published transcriptomic prognostic signatures for prostate cancer

Song Xue, Wei Lei, Xiang Wan, Tubin Yuan, Jin Zhao, Ruiping Su
article en

Abstract

Statistical analysis plan (SAP v2) of UroSig-Reeval, an external re-evaluation of published transcriptomic prognostic signatures for prostate cancer in independent public cohorts, with an English translation and a list of all amendments and post hoc analyses. The plan was finalised on 11 November 2026, before any outcome data were read. It was not registered prospectively and is made public here after the analyses were completed. The original Chinese PDF is the authoritative version (SHA-256 dc9965d5662bfbb408ffbd68f5ef90c57991e4a9765f0a326f7f54745694f110). Jin Zhao and Song Xue contributed equally. Correspondence: Xiang Wan.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon